Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Ultrasound Needle Guides Market

ID: MRFR/HC/26008-HCR
100 Pages
Rahul Gotadki
Last Updated: April 06, 2026

Ultrasound Needle Guides Market Research Report: Size, Share, Trend Analysis By Target Organ (Lung, Liver, Kidney, Prostate, Thyroid), By Procedure Type (Biopsy, Ablation, Aspiration, Drainage), By Needle Type (Core Needle, Fine Needle, Radiofrequency Ablation Needle), By Applications (Medical Diagnostics, Cancer Treatment, Pain Management, Cosmetic Procedures) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Ultrasound Needle Guides Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Target Organ (USD Billion)
  49.     4.1.1 Lung
  50.     4.1.2 Liver
  51.     4.1.3 Kidney
  52.     4.1.4 Prostate
  53.     4.1.5 Thyroid
  54.   4.2 Healthcare, BY Procedure Type (USD Billion)
  55.     4.2.1 Biopsy
  56.     4.2.2 Ablation
  57.     4.2.3 Aspiration
  58.     4.2.4 Drainage
  59.   4.3 Healthcare, BY Needle Type (USD Billion)
  60.     4.3.1 Core Needle
  61.     4.3.2 Fine Needle
  62.     4.3.3 Radiofrequency Ablation Needle
  63.   4.4 Healthcare, BY Application (USD Billion)
  64.     4.4.1 Medical Diagnostics
  65.     4.4.2 Cancer Treatment
  66.     4.4.3 Pain Management
  67.     4.4.4 Cosmetic Procedures
  68.   4.5 Healthcare, BY Region (USD Billion)
  69.     4.5.1 North America
  70.       4.5.1.1 US
  71.       4.5.1.2 Canada
  72.     4.5.2 Europe
  73.       4.5.2.1 Germany
  74.       4.5.2.2 UK
  75.       4.5.2.3 France
  76.       4.5.2.4 Russia
  77.       4.5.2.5 Italy
  78.       4.5.2.6 Spain
  79.       4.5.2.7 Rest of Europe
  80.     4.5.3 APAC
  81.       4.5.3.1 China
  82.       4.5.3.2 India
  83.       4.5.3.3 Japan
  84.       4.5.3.4 South Korea
  85.       4.5.3.5 Malaysia
  86.       4.5.3.6 Thailand
  87.       4.5.3.7 Indonesia
  88.       4.5.3.8 Rest of APAC
  89.     4.5.4 South America
  90.       4.5.4.1 Brazil
  91.       4.5.4.2 Mexico
  92.       4.5.4.3 Argentina
  93.       4.5.4.4 Rest of South America
  94.     4.5.5 MEA
  95.       4.5.5.1 GCC Countries
  96.       4.5.5.2 South Africa
  97.       4.5.5.3 Rest of MEA
  98. 5 SECTION V: COMPETITIVE ANALYSIS
  99.   5.1 Competitive Landscape
  100.     5.1.1 Overview
  101.     5.1.2 Competitive Analysis
  102.     5.1.3 Market share Analysis
  103.     5.1.4 Major Growth Strategy in the Healthcare
  104.     5.1.5 Competitive Benchmarking
  105.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  106.     5.1.7 Key developments and growth strategies
  107.       5.1.7.1 New Product Launch/Service Deployment
  108.       5.1.7.2 Merger & Acquisitions
  109.       5.1.7.3 Joint Ventures
  110.     5.1.8 Major Players Financial Matrix
  111.       5.1.8.1 Sales and Operating Income
  112.       5.1.8.2 Major Players R&D Expenditure. 2023
  113.   5.2 Company Profiles
  114.     5.2.1 GE Healthcare (US)
  115.       5.2.1.1 Financial Overview
  116.       5.2.1.2 Products Offered
  117.       5.2.1.3 Key Developments
  118.       5.2.1.4 SWOT Analysis
  119.       5.2.1.5 Key Strategies
  120.     5.2.2 Philips (NL)
  121.       5.2.2.1 Financial Overview
  122.       5.2.2.2 Products Offered
  123.       5.2.2.3 Key Developments
  124.       5.2.2.4 SWOT Analysis
  125.       5.2.2.5 Key Strategies
  126.     5.2.3 Siemens Healthineers (DE)
  127.       5.2.3.1 Financial Overview
  128.       5.2.3.2 Products Offered
  129.       5.2.3.3 Key Developments
  130.       5.2.3.4 SWOT Analysis
  131.       5.2.3.5 Key Strategies
  132.     5.2.4 Hitachi Medical Systems (JP)
  133.       5.2.4.1 Financial Overview
  134.       5.2.4.2 Products Offered
  135.       5.2.4.3 Key Developments
  136.       5.2.4.4 SWOT Analysis
  137.       5.2.4.5 Key Strategies
  138.     5.2.5 Fujifilm (JP)
  139.       5.2.5.1 Financial Overview
  140.       5.2.5.2 Products Offered
  141.       5.2.5.3 Key Developments
  142.       5.2.5.4 SWOT Analysis
  143.       5.2.5.5 Key Strategies
  144.     5.2.6 Mindray (CN)
  145.       5.2.6.1 Financial Overview
  146.       5.2.6.2 Products Offered
  147.       5.2.6.3 Key Developments
  148.       5.2.6.4 SWOT Analysis
  149.       5.2.6.5 Key Strategies
  150.     5.2.7 Samsung Medison (KR)
  151.       5.2.7.1 Financial Overview
  152.       5.2.7.2 Products Offered
  153.       5.2.7.3 Key Developments
  154.       5.2.7.4 SWOT Analysis
  155.       5.2.7.5 Key Strategies
  156.     5.2.8 Esaote (IT)
  157.       5.2.8.1 Financial Overview
  158.       5.2.8.2 Products Offered
  159.       5.2.8.3 Key Developments
  160.       5.2.8.4 SWOT Analysis
  161.       5.2.8.5 Key Strategies
  162.     5.2.9 Canon Medical Systems (JP)
  163.       5.2.9.1 Financial Overview
  164.       5.2.9.2 Products Offered
  165.       5.2.9.3 Key Developments
  166.       5.2.9.4 SWOT Analysis
  167.       5.2.9.5 Key Strategies
  168.   5.3 Appendix
  169.     5.3.1 References
  170.     5.3.2 Related Reports
  171. 6 LIST OF FIGURES
  172.   6.1 MARKET SYNOPSIS
  173.   6.2 NORTH AMERICA MARKET ANALYSIS
  174.   6.3 US MARKET ANALYSIS BY TARGET ORGAN
  175.   6.4 US MARKET ANALYSIS BY PROCEDURE TYPE
  176.   6.5 US MARKET ANALYSIS BY NEEDLE TYPE
  177.   6.6 US MARKET ANALYSIS BY APPLICATION
  178.   6.7 CANADA MARKET ANALYSIS BY TARGET ORGAN
  179.   6.8 CANADA MARKET ANALYSIS BY PROCEDURE TYPE
  180.   6.9 CANADA MARKET ANALYSIS BY NEEDLE TYPE
  181.   6.10 CANADA MARKET ANALYSIS BY APPLICATION
  182.   6.11 EUROPE MARKET ANALYSIS
  183.   6.12 GERMANY MARKET ANALYSIS BY TARGET ORGAN
  184.   6.13 GERMANY MARKET ANALYSIS BY PROCEDURE TYPE
  185.   6.14 GERMANY MARKET ANALYSIS BY NEEDLE TYPE
  186.   6.15 GERMANY MARKET ANALYSIS BY APPLICATION
  187.   6.16 UK MARKET ANALYSIS BY TARGET ORGAN
  188.   6.17 UK MARKET ANALYSIS BY PROCEDURE TYPE
  189.   6.18 UK MARKET ANALYSIS BY NEEDLE TYPE
  190.   6.19 UK MARKET ANALYSIS BY APPLICATION
  191.   6.20 FRANCE MARKET ANALYSIS BY TARGET ORGAN
  192.   6.21 FRANCE MARKET ANALYSIS BY PROCEDURE TYPE
  193.   6.22 FRANCE MARKET ANALYSIS BY NEEDLE TYPE
  194.   6.23 FRANCE MARKET ANALYSIS BY APPLICATION
  195.   6.24 RUSSIA MARKET ANALYSIS BY TARGET ORGAN
  196.   6.25 RUSSIA MARKET ANALYSIS BY PROCEDURE TYPE
  197.   6.26 RUSSIA MARKET ANALYSIS BY NEEDLE TYPE
  198.   6.27 RUSSIA MARKET ANALYSIS BY APPLICATION
  199.   6.28 ITALY MARKET ANALYSIS BY TARGET ORGAN
  200.   6.29 ITALY MARKET ANALYSIS BY PROCEDURE TYPE
  201.   6.30 ITALY MARKET ANALYSIS BY NEEDLE TYPE
  202.   6.31 ITALY MARKET ANALYSIS BY APPLICATION
  203.   6.32 SPAIN MARKET ANALYSIS BY TARGET ORGAN
  204.   6.33 SPAIN MARKET ANALYSIS BY PROCEDURE TYPE
  205.   6.34 SPAIN MARKET ANALYSIS BY NEEDLE TYPE
  206.   6.35 SPAIN MARKET ANALYSIS BY APPLICATION
  207.   6.36 REST OF EUROPE MARKET ANALYSIS BY TARGET ORGAN
  208.   6.37 REST OF EUROPE MARKET ANALYSIS BY PROCEDURE TYPE
  209.   6.38 REST OF EUROPE MARKET ANALYSIS BY NEEDLE TYPE
  210.   6.39 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
  211.   6.40 APAC MARKET ANALYSIS
  212.   6.41 CHINA MARKET ANALYSIS BY TARGET ORGAN
  213.   6.42 CHINA MARKET ANALYSIS BY PROCEDURE TYPE
  214.   6.43 CHINA MARKET ANALYSIS BY NEEDLE TYPE
  215.   6.44 CHINA MARKET ANALYSIS BY APPLICATION
  216.   6.45 INDIA MARKET ANALYSIS BY TARGET ORGAN
  217.   6.46 INDIA MARKET ANALYSIS BY PROCEDURE TYPE
  218.   6.47 INDIA MARKET ANALYSIS BY NEEDLE TYPE
  219.   6.48 INDIA MARKET ANALYSIS BY APPLICATION
  220.   6.49 JAPAN MARKET ANALYSIS BY TARGET ORGAN
  221.   6.50 JAPAN MARKET ANALYSIS BY PROCEDURE TYPE
  222.   6.51 JAPAN MARKET ANALYSIS BY NEEDLE TYPE
  223.   6.52 JAPAN MARKET ANALYSIS BY APPLICATION
  224.   6.53 SOUTH KOREA MARKET ANALYSIS BY TARGET ORGAN
  225.   6.54 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE TYPE
  226.   6.55 SOUTH KOREA MARKET ANALYSIS BY NEEDLE TYPE
  227.   6.56 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
  228.   6.57 MALAYSIA MARKET ANALYSIS BY TARGET ORGAN
  229.   6.58 MALAYSIA MARKET ANALYSIS BY PROCEDURE TYPE
  230.   6.59 MALAYSIA MARKET ANALYSIS BY NEEDLE TYPE
  231.   6.60 MALAYSIA MARKET ANALYSIS BY APPLICATION
  232.   6.61 THAILAND MARKET ANALYSIS BY TARGET ORGAN
  233.   6.62 THAILAND MARKET ANALYSIS BY PROCEDURE TYPE
  234.   6.63 THAILAND MARKET ANALYSIS BY NEEDLE TYPE
  235.   6.64 THAILAND MARKET ANALYSIS BY APPLICATION
  236.   6.65 INDONESIA MARKET ANALYSIS BY TARGET ORGAN
  237.   6.66 INDONESIA MARKET ANALYSIS BY PROCEDURE TYPE
  238.   6.67 INDONESIA MARKET ANALYSIS BY NEEDLE TYPE
  239.   6.68 INDONESIA MARKET ANALYSIS BY APPLICATION
  240.   6.69 REST OF APAC MARKET ANALYSIS BY TARGET ORGAN
  241.   6.70 REST OF APAC MARKET ANALYSIS BY PROCEDURE TYPE
  242.   6.71 REST OF APAC MARKET ANALYSIS BY NEEDLE TYPE
  243.   6.72 REST OF APAC MARKET ANALYSIS BY APPLICATION
  244.   6.73 SOUTH AMERICA MARKET ANALYSIS
  245.   6.74 BRAZIL MARKET ANALYSIS BY TARGET ORGAN
  246.   6.75 BRAZIL MARKET ANALYSIS BY PROCEDURE TYPE
  247.   6.76 BRAZIL MARKET ANALYSIS BY NEEDLE TYPE
  248.   6.77 BRAZIL MARKET ANALYSIS BY APPLICATION
  249.   6.78 MEXICO MARKET ANALYSIS BY TARGET ORGAN
  250.   6.79 MEXICO MARKET ANALYSIS BY PROCEDURE TYPE
  251.   6.80 MEXICO MARKET ANALYSIS BY NEEDLE TYPE
  252.   6.81 MEXICO MARKET ANALYSIS BY APPLICATION
  253.   6.82 ARGENTINA MARKET ANALYSIS BY TARGET ORGAN
  254.   6.83 ARGENTINA MARKET ANALYSIS BY PROCEDURE TYPE
  255.   6.84 ARGENTINA MARKET ANALYSIS BY NEEDLE TYPE
  256.   6.85 ARGENTINA MARKET ANALYSIS BY APPLICATION
  257.   6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TARGET ORGAN
  258.   6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE TYPE
  259.   6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY NEEDLE TYPE
  260.   6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  261.   6.90 MEA MARKET ANALYSIS
  262.   6.91 GCC COUNTRIES MARKET ANALYSIS BY TARGET ORGAN
  263.   6.92 GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE TYPE
  264.   6.93 GCC COUNTRIES MARKET ANALYSIS BY NEEDLE TYPE
  265.   6.94 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
  266.   6.95 SOUTH AFRICA MARKET ANALYSIS BY TARGET ORGAN
  267.   6.96 SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE TYPE
  268.   6.97 SOUTH AFRICA MARKET ANALYSIS BY NEEDLE TYPE
  269.   6.98 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
  270.   6.99 REST OF MEA MARKET ANALYSIS BY TARGET ORGAN
  271.   6.100 REST OF MEA MARKET ANALYSIS BY PROCEDURE TYPE
  272.   6.101 REST OF MEA MARKET ANALYSIS BY NEEDLE TYPE
  273.   6.102 REST OF MEA MARKET ANALYSIS BY APPLICATION
  274.   6.103 KEY BUYING CRITERIA OF HEALTHCARE
  275.   6.104 RESEARCH PROCESS OF MRFR
  276.   6.105 DRO ANALYSIS OF HEALTHCARE
  277.   6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  278.   6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  279.   6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
  280.   6.109 HEALTHCARE, BY TARGET ORGAN, 2024 (% SHARE)
  281.   6.110 HEALTHCARE, BY TARGET ORGAN, 2024 TO 2035 (USD Billion)
  282.   6.111 HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE)
  283.   6.112 HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion)
  284.   6.113 HEALTHCARE, BY NEEDLE TYPE, 2024 (% SHARE)
  285.   6.114 HEALTHCARE, BY NEEDLE TYPE, 2024 TO 2035 (USD Billion)
  286.   6.115 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  287.   6.116 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  288.   6.117 BENCHMARKING OF MAJOR COMPETITORS
  289. 7 LIST OF TABLES
  290.   7.1 LIST OF ASSUMPTIONS
  291.     7.1.1
  292.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  293.     7.2.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  294.     7.2.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  295.     7.2.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  296.     7.2.4 BY APPLICATION, 2025-2035 (USD Billion)
  297.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  298.     7.3.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  299.     7.3.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  300.     7.3.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  301.     7.3.4 BY APPLICATION, 2025-2035 (USD Billion)
  302.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  303.     7.4.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  304.     7.4.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  305.     7.4.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  306.     7.4.4 BY APPLICATION, 2025-2035 (USD Billion)
  307.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  308.     7.5.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  309.     7.5.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  310.     7.5.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  311.     7.5.4 BY APPLICATION, 2025-2035 (USD Billion)
  312.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  313.     7.6.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  314.     7.6.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  315.     7.6.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  316.     7.6.4 BY APPLICATION, 2025-2035 (USD Billion)
  317.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  318.     7.7.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  319.     7.7.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  320.     7.7.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  321.     7.7.4 BY APPLICATION, 2025-2035 (USD Billion)
  322.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  323.     7.8.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  324.     7.8.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  325.     7.8.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  326.     7.8.4 BY APPLICATION, 2025-2035 (USD Billion)
  327.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  328.     7.9.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  329.     7.9.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  330.     7.9.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  331.     7.9.4 BY APPLICATION, 2025-2035 (USD Billion)
  332.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  333.     7.10.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  334.     7.10.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  335.     7.10.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  336.     7.10.4 BY APPLICATION, 2025-2035 (USD Billion)
  337.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  338.     7.11.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  339.     7.11.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  340.     7.11.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  341.     7.11.4 BY APPLICATION, 2025-2035 (USD Billion)
  342.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  343.     7.12.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  344.     7.12.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  345.     7.12.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  346.     7.12.4 BY APPLICATION, 2025-2035 (USD Billion)
  347.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  348.     7.13.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  349.     7.13.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  350.     7.13.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  351.     7.13.4 BY APPLICATION, 2025-2035 (USD Billion)
  352.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  353.     7.14.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  354.     7.14.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  355.     7.14.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  356.     7.14.4 BY APPLICATION, 2025-2035 (USD Billion)
  357.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  358.     7.15.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  359.     7.15.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  360.     7.15.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  361.     7.15.4 BY APPLICATION, 2025-2035 (USD Billion)
  362.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  363.     7.16.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  364.     7.16.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  365.     7.16.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  366.     7.16.4 BY APPLICATION, 2025-2035 (USD Billion)
  367.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  368.     7.17.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  369.     7.17.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  370.     7.17.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  371.     7.17.4 BY APPLICATION, 2025-2035 (USD Billion)
  372.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  373.     7.18.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  374.     7.18.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  375.     7.18.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  376.     7.18.4 BY APPLICATION, 2025-2035 (USD Billion)
  377.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  378.     7.19.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  379.     7.19.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  380.     7.19.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  381.     7.19.4 BY APPLICATION, 2025-2035 (USD Billion)
  382.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  383.     7.20.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  384.     7.20.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  385.     7.20.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  386.     7.20.4 BY APPLICATION, 2025-2035 (USD Billion)
  387.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  388.     7.21.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  389.     7.21.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  390.     7.21.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  391.     7.21.4 BY APPLICATION, 2025-2035 (USD Billion)
  392.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  393.     7.22.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  394.     7.22.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  395.     7.22.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  396.     7.22.4 BY APPLICATION, 2025-2035 (USD Billion)
  397.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  398.     7.23.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  399.     7.23.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  400.     7.23.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  401.     7.23.4 BY APPLICATION, 2025-2035 (USD Billion)
  402.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  403.     7.24.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  404.     7.24.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  405.     7.24.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  406.     7.24.4 BY APPLICATION, 2025-2035 (USD Billion)
  407.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  408.     7.25.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  409.     7.25.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  410.     7.25.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  411.     7.25.4 BY APPLICATION, 2025-2035 (USD Billion)
  412.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  413.     7.26.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  414.     7.26.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  415.     7.26.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  416.     7.26.4 BY APPLICATION, 2025-2035 (USD Billion)
  417.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  418.     7.27.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  419.     7.27.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  420.     7.27.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  421.     7.27.4 BY APPLICATION, 2025-2035 (USD Billion)
  422.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  423.     7.28.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  424.     7.28.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  425.     7.28.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  426.     7.28.4 BY APPLICATION, 2025-2035 (USD Billion)
  427.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  428.     7.29.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  429.     7.29.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  430.     7.29.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  431.     7.29.4 BY APPLICATION, 2025-2035 (USD Billion)
  432.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  433.     7.30.1 BY TARGET ORGAN, 2025-2035 (USD Billion)
  434.     7.30.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  435.     7.30.3 BY NEEDLE TYPE, 2025-2035 (USD Billion)
  436.     7.30.4 BY APPLICATION, 2025-2035 (USD Billion)
  437.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  438.     7.31.1
  439.   7.32 ACQUISITION/PARTNERSHIP
  440.     7.32.1

Healthcare Market Segmentation

Healthcare By Target Organ (USD Billion, 2025-2035)

  • Lung
  • Liver
  • Kidney
  • Prostate
  • Thyroid

Healthcare By Procedure Type (USD Billion, 2025-2035)

  • Biopsy
  • Ablation
  • Aspiration
  • Drainage

Healthcare By Needle Type (USD Billion, 2025-2035)

  • Core Needle
  • Fine Needle
  • Radiofrequency Ablation Needle

Healthcare By Application (USD Billion, 2025-2035)

  • Medical Diagnostics
  • Cancer Treatment
  • Pain Management
  • Cosmetic Procedures

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions